March 24, 2026

Case Study: Accelerated Out-Licensing Strategy and Commercial Validation for a Phase 2 Biotech

The Challenge


A Phase 2 biotechnology company needed to rapidly evaluate its competitive landscape to identify viable out-licensing partners for its lead asset.

Relying on fragmented business intelligence subscriptions and siloed internal data left critical blind spots in their competitive intelligence, delaying the creation of a data-backed commercial partnering package.

The Omnitheia Solution


The client deployed Omnitheia’s Integrated Insights platform to consolidate desk research, data analytics, and primary market research into a single workflow.

  • Landscape Mapping: The AI engine scanned 100k+ live industry documents to instantly generate a comprehensive map of direct competitors and a prioritised list of potential out-licensing partners.

  • Gap Analysis and Evidence Builder: The client uploaded proprietary clinical reports into the platform. Omnitheia cross-referenced this against external intelligence, flagging competitive assets the client missed.The Evidence Builder generated an initial Confidence Score of 85% (for the Licensing valuation).

  • PMR Intelligence: The system flagged the 15% low-confidence gap as a  need for further validation. Our PMR Intelligence module anticipated KOL objections, guided the client on framing interview questions to highlight their drug’s USPs & the insights provided the real-world evidence framework needed to back their analysis.

  • Expert Validation: Omnitheia’s in-house experts conducted custom interviews with global KOLs. Delivered within 48 hours, these insights provided the necessary real-world validation to overcome objections, elevating the Confidence score as well as defensibility of their analysis.

Impact & Key Results


The biotech firm successfully built a robust, defensible licensing strategy without having to purchase & manage multiple fragmented subscriptions/vendors.

  • 25% Reduction in BI Spend: Consolidated external intelligence access, eliminating redundant subscriptions.

  • 50% Reduction in PMR Costs and Time: Executed live, expert-moderated primary research within 48 hours.

  • Accelerated Deal Readiness: Delivered a fully triangulated, 100% validated commercial package for upcoming negotiations.



Follow Omnitheia on LinkedIn for real-time insights and strategic discussions.